228 related articles for article (PubMed ID: 27391337)
1. Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.
Ma JW; Hung CM; Lin YC; Ho CT; Kao JY; Way TD
Oncotarget; 2016 Sep; 7(37):58915-58930. PubMed ID: 27391337
[TBL] [Abstract][Full Text] [Related]
2. Aloe-Emodin Enhances Tamoxifen Cytotoxicity by Suppressing Ras/ERK and PI3K/mTOR in Breast Cancer Cells.
Tseng HS; Wang YF; Tzeng YM; Chen DR; Liao YF; Chiu HY; Hsieh WT
Am J Chin Med; 2017; 45(2):337-350. PubMed ID: 28231748
[TBL] [Abstract][Full Text] [Related]
3. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
4. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
Lou L; Wang J; Lv F; Wang G; Li Y; Xing L; Shen H; Zhang X
Cell Oncol (Dordr); 2021 Feb; 44(1):109-133. PubMed ID: 32894437
[TBL] [Abstract][Full Text] [Related]
5. Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway
Dou F; Liu Y; Liu L; Wang J; Sun T; Mu F; Guo Q; Guo C; Jia N; Liu W; Ding Y; Wen A
Rejuvenation Res; 2019 Jun; 22(3):218-229. PubMed ID: 30215298
[TBL] [Abstract][Full Text] [Related]
6. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages.
Hu B; Zhang H; Meng X; Wang F; Wang P
J Ethnopharmacol; 2014 May; 153(3):846-53. PubMed ID: 24685589
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC
Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184
[TBL] [Abstract][Full Text] [Related]
8. Aloe-emodin prevents nerve injury and neuroinflammation caused by ischemic stroke via the PI3K/AKT/mTOR and NF-κB pathway.
Xian M; Cai J; Zheng K; Liu Q; Liu Y; Lin H; Liang S; Wang S
Food Funct; 2021 Sep; 12(17):8056-8067. PubMed ID: 34286782
[TBL] [Abstract][Full Text] [Related]
9. Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathways.
Zhang J; Guo L; Zhang Q; Liu K; Dong Z
Mol Med Rep; 2018 Dec; 18(6):5215-5220. PubMed ID: 30272294
[TBL] [Abstract][Full Text] [Related]
10. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.
Chen YY; Chiang SY; Lin JG; Ma YS; Liao CL; Weng SW; Lai TY; Chung JG
Int J Oncol; 2010 May; 36(5):1113-20. PubMed ID: 20372784
[TBL] [Abstract][Full Text] [Related]
11. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
13. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.
Zhang L; Chang CJ; Bacus SS; Hung MC
Cancer Res; 1995 Sep; 55(17):3890-6. PubMed ID: 7543819
[TBL] [Abstract][Full Text] [Related]
14. Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.
Law JH; Li Y; To K; Wang M; Astanehe A; Lambie K; Dhillon J; Jones SJ; Gleave ME; Eaves CJ; Dunn SE
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844753
[TBL] [Abstract][Full Text] [Related]
15. Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways.
Kim HJ; Choi JW; Ree J; Lim JS; Lee J; Kim JI; Thapa SB; Sohng JK; Park YI
Life Sci; 2022 Jul; 300():120495. PubMed ID: 35341826
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
Wu J; Lee C; Yokom D; Jiang H; Cheang MC; Yorida E; Turbin D; Berquin IM; Mertens PR; Iftner T; Gilks CB; Dunn SE
Cancer Res; 2006 May; 66(9):4872-9. PubMed ID: 16651443
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Aloe emodin on invasion and metastasis of high metastatic breast cancer MDA-MB-231 cells].
He ZH; Huang YQ; Weng SF; Tan YR; He TP; Qin YM; Liang NC
Zhong Yao Cai; 2013 Sep; 36(9):1481-5. PubMed ID: 24620697
[TBL] [Abstract][Full Text] [Related]
18. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.
Zhang L; Lau YK; Xi L; Hong RL; Kim DS; Chen CF; Hortobagyi GN; Chang C; Hung MC
Oncogene; 1998 Jun; 16(22):2855-63. PubMed ID: 9671406
[TBL] [Abstract][Full Text] [Related]
20. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
